Identification of Potential New Protein Vaccine Candidates through Pan-Surfomic Analysis of Pneumococcal Clinical Isolates from Adults

作者: Alfonso Olaya-Abril , Irene Jiménez-Munguía , Lidia Gómez-Gascón , Ignacio Obando , Manuel J. Rodríguez-Ortega

DOI: 10.1371/JOURNAL.PONE.0070365

关键词: MicrobiologyPneumococcal infectionsStreptococcus pneumoniaeSerotypeImmunogenicityBiologyVirologyAntigenPathogenProteaseAntibodyGeneral Biochemistry, Genetics and Molecular BiologyGeneral Agricultural and Biological SciencesGeneral Medicine

摘要: Purified polysaccharide and conjugate vaccines are widely used for preventing infections in adults children against the Gram-positive bacterium Streptococcus pneumoniae, a pathogen responsible high morbidity mortality rates, especially developing countries. However, these polysaccharide-based have some important limitations, such as being serotype-dependent, subjected to losing efficacy because of serotype replacement manufacturing complexity cost. It is expected that protein-based will overcome issues by conferring broad coverage independent lowering production costs. In this study, we applied “shaving” proteomic approach, consisting LC/MS/MS analysis peptides generated protease treatment live cells, collection 16 pneumococcal clinical isolates from adults, representing most prevalent strains circulating Spain during last years. The set unique proteins identified all isolates, called “pan-surfome”, consisted 254 proteins, which included protective protein antigens reported so far. search new candidates with vaccine potential, 32 were present at least 50% analyzed. We selected four them (Spr0012, Spr0328, Spr0561 SP670_2141), whose protection capacity has not yet been tested, assaying immunogenicity human sera. All induced IgM antibodies infected patients, thus indicating they could enter pipeline studies. pan-surfomic approach shows its utility discovery can elicit infectious microorganisms.

参考文章(71)
Guido Grandi, Genomics and proteomics in reverse vaccines. Methods of biochemical analysis. ,vol. 49, pp. 379- 393 ,(2005) , 10.1002/0471973165.CH20
C. Morsczeck, T. Prokhorova, J. Sigh, M. Pfeiffer, M. Bille-Nielsen, J. Petersen, A. Boysen, T. Kofoed, N. Frimodt-Møller, P. Nyborg-Nielsen, P. Schrotz-King, Streptococcus pneumoniae: proteomics of surface proteins for vaccine development. Clinical Microbiology and Infection. ,vol. 14, pp. 74- 81 ,(2008) , 10.1111/J.1469-0691.2007.01878.X
J.D. Grabenstein, K.P. Klugman, A century of pneumococcal vaccination research in humans Clinical Microbiology and Infection. ,vol. 18, pp. 15- 24 ,(2012) , 10.1111/J.1469-0691.2012.03943.X
F. Blasi, M. Mantero, PierAchille Santus, P. Tarsia, Understanding the burden of pneumococcal disease in adults Clinical Microbiology and Infection. ,vol. 18, pp. 7- 14 ,(2012) , 10.1111/J.1469-0691.2012.03937.X
A. Hagerman, K.M. Posfay-Barbe, S. Grillet, M.M. Ochs, R.H. Brookes, D. Greenberg, N. Givon-Lavi, R. Dagan, C.-A. Siegrist, Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia Clinical Microbiology and Infection. ,vol. 18, pp. 756- 762 ,(2012) , 10.1111/J.1469-0691.2011.03629.X
Deborah F. Talkington, Bobby G. Brown, Jean A. Tharpe, Amie Koenig, Harold Russell, Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA) Microbial Pathogenesis. ,vol. 21, pp. 17- 22 ,(1996) , 10.1006/MPAT.1996.0038
Maxim Portnoi, Eduard Ling, Galia Feldman, Ron Dagan, Yaffa Mizrachi-Nebenzahl, The vaccine potential of Streptococcus pneumoniae surface lectin- and non-lectin proteins Vaccine. ,vol. 24, pp. 1868- 1873 ,(2006) , 10.1016/J.VACCINE.2005.10.053
E. LING, G. FELDMAN, M. PORTNOI, R. DAGAN, K. OVERWEG, F. MULHOLLAND, V. CHALIFA-CASPI, J. WELLS, Y. MIZRACHI-NEBENZAHL, Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse Clinical and Experimental Immunology. ,vol. 138, pp. 290- 298 ,(2004) , 10.1111/J.1365-2249.2004.02628.X
M. Mora, G. Bensi, S. Capo, F. Falugi, C. Zingaretti, A. G. O. Manetti, T. Maggi, A. R. Taddei, G. Grandi, J. L. Telford, Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 15641- 15646 ,(2005) , 10.1073/PNAS.0507808102